Sign in
4

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0000914190-14-000121

Options or other derivatives

  • Chief Financial Officer acquired 40,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Hippel James · Chief Financial Officer

Table II: Derivative

3 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2014-04-01 Grant or award : show line 1 in the form Stock Option (Right to Buy) +25,000 $86.25 2021-04-01 25,000 25,000 D
2014-04-01 Grant or award : show line 2 in the form Stock Option (Right to Buy) +10,000 $86.25 2021-04-01 10,000 10,000 D
2014-04-01 Grant or award : show line 3 in the form Restricted Stock Units +5,000 5,000 5,000 D
Loading xslF345X03/edgar.xml…